ZimVie Inc (FRA:O23)
€ 13.6 0 (0%) Market Cap: 385.72 Mil Enterprise Value: 544.21 Mil PE Ratio: 0 PB Ratio: 1.00 GF Score: 45/100

ZimVie Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2022 / 11:20AM GMT
Release Date Price: €14.7 (+2.80%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Good morning everyone. Welcome to Day 2 of the Morgan Stanley Healthcare Conference. I'm Drew Ranieri, one of the Med Tech Analysts here. I'm delighted to be joined today by members of the ZimVie management team; Vafa Jamali and Rich Heppenstall, the CEO and CFO of the company.

Before we jump in, just a quick disclaimer before important disclosures, please see the Morgan Stanley research disclosure website. And if you have any questions, please reach out here at Morgan Stanley sales rep.

With that, Vafa, Rich, I think it would be helpful and thanks again for being here today. Great to have you both in person. And my sense is, this is the first conference and first in-person conference that you've been at since the spin happened in early March. But maybe just spend a few minutes and just introduce ZimVie. Give us a sense of the portfolio, the markets you're playing in today.

Vafa Jamali
ZimVie Inc. - President, CEO & Director

Great. Thanks for having us. It's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot